bioAffinity Technologies Inc. (BIAF) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for bioAffinity Technologies Inc., updated every trading day.
Health Care · Biotechnology: Commercial Physical & Biological Resarch
Price
$3.14
+6.08% today
Market cap
$4M
Overall quality
36/100
Kronos AI 30-day
+247.6%
8 of 8 simulated paths end higher
bioAffinity Technologies Inc. (BIAF) is a Health Care company in Biotechnology: Commercial Physical & Biological Resarch, worth $4M. It trades at $3.14, up 6.08% today. Its overall quality score is 36 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is +247.6% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $10.29 (+247.6%) |
| Likely range | +181.6% … +349.3% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 5 |
| Solvency | 49 |
| Growth | 55 |
| Overall | 36 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Commercial Physical & Biological Resarch
For information only, not investment advice. Prices updated: 2026-10-29.